Abstract
Background
The objective of this study is the comparison of a new intragastric balloon recently introduced, the Adjustable Balloon System (ABS), with the BioEnterics intragastric balloon (BIB) in terms of tolerance, safety, and weight loss parameters.
Methods
A case–control study was done: 40 patients were matched with 80 controls. To achieve the same duration therapy (12 months), a single ABS positioning was compared with a BIB followed by another BIB (6 + 6 months). Length of procedure, hospital stay, complications, and weight loss parameters after 6 months (time of first BIB removal) and after 12 months from baseline (time of Spatz and second BIB removal) were considered. Statistical analysis was done by means of Student’s t test, χ2 test, or Fisher’s test. P < 0.05 was considered significant.
Results
Mortality, positioning, and extraction complications were absent. Both the devices were well tolerated with slight duration of post placement symptoms. During this study, the Spatz balloon was adjusted with inflation of 200 cm3 of saline (total, 800 cm3) in 9/40 (22.5 %) patients, for poor weight loss after first 6-months treatment. In the Spatz group, there occurred 7/40 complications linked to the device and in 6/7 patients the balloon was removed. At the end of the study, the weight loss parameters were similar between groups: BMI 31.0 ± 11.8 (Spatz group) vs 31.3 ± 12.3 (BIB group) (p = Ns).
Conclusions
The idea of dynamic balloon therapy needs to be confirmed with wider series. The rate of complication reported is very high, and several studies regarding safety and efficacy are needed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Genco A, Balducci S, Bacci V, et al. Intragastric balloon or diet alone? A retrospective evaluation. Obes Surg. 2008;18(8):989–92.
Imaz I, Martinez-Cervell C, Garcia-Alvarez EE, et al. Safety and effectiveness of the intragastric balloon for obesity. A meta-analysis. Obes Surg. 2008;18:841–6.
Angrisani L, Lorenzo M, Borrelli V, et al. Is bariatric surgery necessary after intragastric balloon treatment? Obes Surg. 2006;16:1135–7.
Al-Momen A, El-Mogy I. Intragastric balloon for obesity: a retrospective evaluation of tolerance and efficacy. Obes Surg. 2005;15(1):101–5.
De Waele B, Reynaert H, Urbain D, et al. Intragastric balloons for preoperative weight reduction. Obes Surg. 2000;10(1):58–60.
Machytka E, Klvana P, Kornbluth A, et al. Adjustable Intragastric Balloons: a 12-months pilot trial in endoscopic weight loss management. Obes Surg. 2011;21:1499–507.
Espinet-Coll E, Nebreda-Duran J, Gomez-Valero JA, et al. Current endoscopic techniques in the treatment of obesity. Rev Esp Enferm Dig. 2012;104:72–87.
Genco A, Cipriano M, Bacci V, et al. Intragastric balloon followed by diet vs intragastric balloon followed by another balloon. A prospective study on 100 patients. Obes Surg. 2010;20(11):1096–500.
Schapiro M, Benjamin S, Blackburn G, et al. Obesity and the gastric balloon: a comprehensive workshop. Tarpon springs, Florida, March 19–21, 1987. Gastrointest Endosc. 1987;33:323–7.
Genco A, Cipriano M, Bacci V, et al. Bioenterics intragastric balloon (BIB): a double blind, randomised, controlled, cross-over study. Int J Obes. 2006;30:129–3.
NIH Conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med. 1991;115:956–61.
Messina T, Genco A, Favaro R, et al. Intragastric balloon positioning and removal: sedation or general anesthesia? Surg Endosc. 2011;25:3811–4.
Tsesmeli N, Cosimaros D. The future of bariatrics: endoscopy, endoluminal surgery, and natural orifice transluminal endoscopic surgery. Endoscopy. 2010;42:155–62.
De la Riva S, Munoz-Navas M, Rodriguez-Lago I, et al. Small bowel migration: possible complication of adjustable intragastric balloon. Endoscopy. 2012;44:E224.
Villalonga R, Valverde S, Caubet E. Intestinal occlusion as unusual complication of new intragastric balloon Spatz Adjustable Balloon system for treatment of morbid obesity. Surg Obes Relat Dis. 2013;9(1):e16–7. doi:10.1016/j.soard.2011.12.007.
Dumonceau LM. Evidence based review of the BioEnterics intragastric balloon for weight loss. Obes Surg. 2008;18:1611–7.
Spyropoulos C, Katsakoulis E, Mead N, et al. Intragastric balloon for high risk super-obese patients: a prospective analysis of efficacy. Surg Obes Relat Dis. 2007;3:78–83.
Lopez-Nava G, Rubio MA, Prados S, et al. BioEnterics intragastric balloon (BIB). Single Ambulatory Center Spanish Experience with 714 consecutive patients treated with one or two consecutive balloons. Obes Surg. 2011;21:5–9.
Genco A, Bruni T, Doldi SB, et al. BioEnterics intragastric balloon: the Italian experience with 2,515 patients. Obes Surg. 2005;15:1161–4.
Conflict of Interest
The authors declare that they have no conflict of interest
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Genco, A., Dellepiane, D., Baglio, G. et al. Adjustable Intragastric Balloon vs Non-Adjustable Intragastric Balloon: Case–Control Study on Complications, Tolerance, and Efficacy. OBES SURG 23, 953–958 (2013). https://doi.org/10.1007/s11695-013-0891-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-013-0891-5